Explore 3 Stock Ideas & Industry Insights Download Free Report

Wellgistics Health, Inc. Common Stock

Company price
None USD 0.00(0%)
Last update at 2026-11-16T10:20:19.764855Z
Market Cap
182.88M

Momentum Score

…

Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
2.48
Low
75.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Wellgistics Health, Inc. (NASDAQ: WGRX) is limited; the company's filings and public disclosures do not clearly describe its core operations or product lines, which constrains a detailed assessment. Long-term growth would depend on clarifying the business model, achieving commercial traction and regulatory compliance, factors that may attract investors seeking early-stage healthcare exposure if the company delivers transparent strategy and execution.
The most important investment risks are sparse public disclosure and information asymmetry, likely low trading liquidity, unclear operating history and execution risk, plus potential financial and regulatory uncertainty typical for small healthcare issuers.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
14.03M
Revenue Per Share
8.34
Gross Profit TTM
-6.95M
Debt / Equity
-1.99
ROE
-927.67%
Net Debt
24.73M
ROCE
-14234.06%
Diluted EPS TTM
-43.87

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Income before tax -101.27M -6.86M -2.90M -2.74M
Net income -101.27M -6.86M -2.90M -2.74M
Selling general administrative 70.33M 6.80M 2.88M 7.08M
Selling and marketing expenses 1.22M - - -
Gross profit -9.64M 1.77M 0.00M 5.75M
Reconciled depreciation 3.21M 1.11M 0.00M 2.09M
Ebit -96.69M -6.02M - -2.46M
Ebitda -93.48M -4.91M -2.88M -0.37M
Depreciation and amortization 3.21M 1.11M - 2.09M
Operating income -81.19M -6.15M -2.88M -3.42M
Other operating expenses 104.53M 24.27M 2.88M 36.20M
Interest expense 4.58M 0.83M 0.02M 0.29M
Tax provision 0.00M 0.00M 0.00M 0.00M
Net interest income -4.58M -0.83M -0.02M -0.29M
Total revenue 23.34M 18.13M 0.00M 32.78M
Total operating expenses 71.56M 7.91M 2.88M 9.17M
Cost of revenue 32.98M 16.36M 0.00M 27.03M
Total other income expense net -20.08M -0.71M -0.02M 0.68M
Net income from continuing ops -101.27M -6.86M -2.90M -2.74M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total assets 30.46M 57.33M 0.34M 0.00M
Intangible assets 10.31M 22.36M - -
Other current assets - 0.88M - -
Total liab 42.91M 50.60M 3.24M 0.01M
Total stockholder equity -12.45M 6.73M -2.90M -0.01M
Other current liab 5.96M 18.91M 1.50M -
Common stock 0.01M 0.01M 0.00M -
Capital stock 0.01M 0.01M 0.00M 0.00M
Retained earnings -111.03M -9.76M -2.90M -0.01M
Good will 14.19M 16.22M 0.00M -
Cash 0.04M 1.03M 0.00M 0.00M
Total current liabilities 29.78M 38.05M 2.89M 0.01M
Current deferred revenue 0.49M 0.25M - -
Net debt 24.73M 24.08M 0.70M -
Short term debt 11.64M 12.56M 0.35M -
Short long term debt 11.07M 12.04M 0.35M -
Short long term debt total 24.77M 25.11M 0.70M -
Other stockholder equity 98.57M 16.49M -0.00M -
Total current assets 2.82M 15.17M 0.34M 0.00M
Long term investments - 0.02M 0.00M -
Net receivables 1.14M 3.75M 0.34M -
Long term debt 12.60M 11.46M 0.35M -
Inventory 1.64M 9.52M 0.00M -
Accounts payable 11.69M 6.33M 1.04M 0.01M
Non currrent assets other 1.94M 1.65M - -
Non current assets total 27.64M 42.16M 0.00M 0.00M
Capital lease obligations 1.10M 1.62M 0.00M -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Type yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Investments - 0.47M 0.00M -
Total cashflows from investing activities -0.88M 0.47M - -
Net borrowings -2.08M 0.62M 0.35M 0.00M
Total cash from financing activities 10.75M 1.78M 0.35M 0.00M
Net income -101.27M -6.86M -2.90M -0.01M
Change in cash -0.99M 1.03M 0.00M 0.00M
Begin period cash flow 1.03M 0.00M 0.00M 0.00M
End period cash flow 0.04M 1.03M 0.00M 0.00M
Total cash from operating activities -10.86M -1.22M -0.35M 0.00M
Issuance of capital stock 11.37M 0.01M 0.00M 0.00M
Depreciation 0.19M 1.11M 0.00M -
Other cashflows from investing activities -0.88M -0.09M - -
Change to inventory 1.89M -0.07M 0.00M -
Change to account receivables 0.80M -0.04M -0.27M -
Sale purchase of stock 2.84M - - -
Other cashflows from financing activities 10.75M 1.15M - -
Capital expenditures 0.88M 0.38M 0.00M 0.00M
Change in working capital 8.48M 3.34M 2.55M 0.01M
Stock based compensation 54.79M 1.08M 0.00M -
Other non cash items 26.95M 0.09M - -
Free cash flow -10.86M -1.60M -0.35M 0.00M

Peer Comparison*

Sector: Healthcare Industry: Medical Distribution

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
MCK
McKesson Corporation
25.76
2.39%
1102.81 24.45 20.41 0.26 5.04 0.27
COR
Cencora Inc.
9.65
2.76%
359.03 24.22 16.39 0.19 20.41 0.21
CAH
Cardinal Health Inc
2.96
1.06%
281.10 29.48 17.92 0.20 16.07 0.22
HSIC
Henry Schein Inc
0.08
0.09%
86.22 25.89 15.08 0.72 3.14 1.00

Profile*

Wellgistics Health, Inc. Common Stock

Wellgistics Health, Inc. engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

3000 Bayport Drive, Tampa, FL, United States, 33607

844 203 6092

Name Title Year Born
Mr. Prashant Patel M.Sc., R.Ph. Interim Co-CEO, President & Director 1975
Dr. Shafaat Pirani Pharm.D. Chief Clinical Officer 1990
Mr. Nikul Panchal BCNP, R.Ph. Senior Vice President of Pharmacy 1978
Raj Mehta M.B.A. SVP of Tech and Hub NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…